530 related articles for article (PubMed ID: 37093543)
1. Longitudinal changes of health-related quality of life over 10 years in breast cancer patients treated with radiotherapy following breast-conserving surgery.
Gao Y; Rosas JC; Fink H; Behrens S; Chang-Claude J; Seibold P
Qual Life Res; 2023 Sep; 32(9):2639-2652. PubMed ID: 37093543
[TBL] [Abstract][Full Text] [Related]
2. Long-term trajectory of postoperative health-related quality of life in young breast cancer patients: a 15-year follow-up study.
Tran TXM; Jung SY; Lee EG; Cho H; Cho J; Lee E; Chang YJ; Cho H
J Cancer Surviv; 2023 Oct; 17(5):1416-1426. PubMed ID: 35279800
[TBL] [Abstract][Full Text] [Related]
3. Diversity in changes of HRQoL over a 1-year period after radiotherapy in Norwegian breast cancer patients: results of cluster analyses.
Lazarewicz MA; Wlodarczyk D; Lundgren S; Reidunsdatter RJ
Qual Life Res; 2019 Jun; 28(6):1521-1530. PubMed ID: 30729449
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany.
Doege D; Thong MS; Koch-Gallenkamp L; Bertram H; Eberle A; Holleczek B; Pritzkuleit R; Waldeyer-Sauerland M; Waldmann A; Zeissig SR; Jansen L; Brenner H; Arndt V
Breast Cancer Res Treat; 2019 Jun; 175(2):499-510. PubMed ID: 30826935
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy.
Versmessen H; Vinh-Hung V; Van Parijs H; Miedema G; Voordeckers M; Adriaenssens N; Storme G; De Ridder M
BMC Cancer; 2012 Oct; 12():495. PubMed ID: 23098579
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in long term breast cancer survivors treated with breast conserving therapy: impact of age at therapy.
Fehlauer F; Tribius S; Mehnert A; Rades D
Breast Cancer Res Treat; 2005 Aug; 92(3):217-22. PubMed ID: 16155792
[TBL] [Abstract][Full Text] [Related]
7. Health-Related Quality of Life in a Cohort of Breast Cancer Survivors over More Than 10 Years Post-Diagnosis and in Comparison to a Control Cohort.
Maurer T; Thöne K; Obi N; Jung AY; Behrens S; Becher H; Chang-Claude J
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33924513
[No Abstract] [Full Text] [Related]
8. Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis.
Schmidt ME; Wiskemann J; Steindorf K
Qual Life Res; 2018 Aug; 27(8):2077-2086. PubMed ID: 29740782
[TBL] [Abstract][Full Text] [Related]
9. The impact of age on changes in quality of life among breast cancer survivors treated with breast-conserving surgery and radiotherapy.
Bantema-Joppe EJ; de Bock GH; Woltman-van Iersel M; Busz DM; Ranchor AV; Langendijk JA; Maduro JH; van den Heuvel ER
Br J Cancer; 2015 Feb; 112(4):636-43. PubMed ID: 25602967
[TBL] [Abstract][Full Text] [Related]
10. Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors.
Doege D; Thong MSY; Koch-Gallenkamp L; Bertram H; Eberle A; Holleczek B; Nennecke A; Pritzkuleit R; Waldmann A; Zeissig SR; Brenner H; Arndt V
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3461-3473. PubMed ID: 35879433
[TBL] [Abstract][Full Text] [Related]
11. Breast conserving surgery versus mastectomy: the effect of surgery on quality of life in breast cancer survivors in Malaysia.
Dahlui M; Azzani M; Taib NA; Hoong SM; Jamaris S; Islam T
BMC Womens Health; 2023 Nov; 23(1):607. PubMed ID: 37974118
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial of post-operative radiotherapy following breast-conserving surgery in a minimum-risk population. Quality of life at 5 years in the PRIME trial.
Williams LJ; Kunkler IH; King CC; Jack W; van der Pol M
Health Technol Assess; 2011 Mar; 15(12):i-xi, 1-57. PubMed ID: 21366974
[TBL] [Abstract][Full Text] [Related]
13. Sexual functioning, sexual enjoyment, and body image in Norwegian breast cancer survivors: a 12-year longitudinal follow-up study and comparison with the general female population.
Åsberg RE; Giskeødegård GF; Raj SX; Karlsen J; Engstrøm M; Salvesen Ø; Nilsen M; Lundgren S; Reidunsdatter RJ
Acta Oncol; 2023 Jul; 62(7):719-727. PubMed ID: 37534752
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
Twelves C; Cortés J; O'Shaughnessy J; Awada A; Perez EA; Im SA; Gómez-Pardo P; Schwartzberg LS; Diéras V; Yardley DA; Potter DA; Mailliez A; Moreno-Aspitia A; Ahn JS; Zhao C; Hoch U; Tagliaferri M; Hannah AL; Rugo HS
Eur J Cancer; 2017 May; 76():205-215. PubMed ID: 28360015
[TBL] [Abstract][Full Text] [Related]
15. Relationship between anxiety disorders and domains of health related quality of life among Nigerians with breast cancer.
Fatiregun OA; Olagunju AT; Erinfolami AR; Arogunmati OA; Fatiregun OA; Adeyemi JD
Breast; 2017 Feb; 31():150-156. PubMed ID: 27866090
[TBL] [Abstract][Full Text] [Related]
16. Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial.
Meattini I; Saieva C; Miccinesi G; Desideri I; Francolini G; Scotti V; Marrazzo L; Pallotta S; Meacci F; Muntoni C; Bendinelli B; Sanchez LJ; Bernini M; Orzalesi L; Nori J; Bianchi S; Livi L
Eur J Cancer; 2017 May; 76():17-26. PubMed ID: 28262584
[TBL] [Abstract][Full Text] [Related]
17. A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer.
Garsa AA; Ferraro DJ; DeWees TA; Deshields TL; Margenthaler JA; Cyr AE; Naughton M; Aft R; Gillanders WE; Eberlein T; Matesa MA; Ochoa LL; Zoberi I
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1043-50. PubMed ID: 24161428
[TBL] [Abstract][Full Text] [Related]
18. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
19. Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial.
Noordman BJ; Verdam MGE; Lagarde SM; Shapiro J; Hulshof MCCM; van Berge Henegouwen MI; Wijnhoven BPL; Nieuwenhuijzen GAP; Bonenkamp JJ; Cuesta MA; Plukker JTM; Spillenaar Bilgen EJ; Steyerberg EW; van der Gaast A; Sprangers MAG; van Lanschot JJB;
Ann Oncol; 2018 Feb; 29(2):445-451. PubMed ID: 29126244
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported Quality of Life After Breast-conserving Surgery With Radiotherapy Versus Mastectomy and Reconstruction.
Diao K; Lei X; He W; Jagsi R; Giordano SH; Smith GL; Caudle A; Shen Y; Peterson SK; Smith BD
Ann Surg; 2023 Nov; 278(5):e1096-e1102. PubMed ID: 37232937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
